[Adamson feels that drug developers are unreasonably concerned about rare events.] The reality is children tolerate phase I therapy [new agents being tested to find the best dosage and possible side-effects] as well as or better than adults, ... Once the initial studies are done – that is, phase I trials in adults – study should begin in children.
For many children current therapies are curative. But the price they pay in long-term side effects is far too high.
Our ability to move ahead has waned. Overcoming the most difficult cancers with higher doses is not likely to succeed anymore.
There's a desperate need for new approaches,
There's a desperate need for new approaches. The success in pediatric oncology has been made with drugs that have been around for 30 years.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.